Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy.

Current Medical Science
Yuan-Yuan GuoDe-Hao Fu

Abstract

Improvements in the diagnosis and treatment of cancer are urgently needed for use in nanotechnology. Nanoparticles (NPs) can reduce the side effects of traditional chemotherapy by sustained release of loaded drugs and increase therapeutic efficiency. NPs can also enhance endothelial permeation retention by size effect and its accumulation in tumor cells through passive targeting. Furthermore, it is critical to treat cancer with a controlled targeted drug which can be specifically delivered into tumor cells and released there, resulting in a targeted therapy to eradicate tumor cells while sparing normal cells. To this end, antibody-mediated targeting therapy has been developed, but imperfections in antibodies (Abs) limit this therapy. Therefore, the combination of NPs and Abs has been highly valued in recent years, because conjugating special Abs on the surface of NPs can increase targeting efficiency, enabling selective delivery of anti-cancer drugs to tumor cells. In this mini-review, we would like to enumerate the strategies for the conjugation of Abs to the surface of the NPs as well as the precise engineering of targeted NPs. The application of targeting antibody fragments in this drug delivery system will also be discussed.

References

Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Frank GuOmid C Farokhzad
Feb 11, 2010·Biomaterials·Fahima DilnawazSanjeeb K Sahoo
Mar 11, 2010·Breast Cancer Research and Treatment·Laura B CarpinRebekah A Drezek
Jul 14, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Chung-Hao WangChing-An Peng
Aug 11, 2010·International Journal of Pharmaceutics·A BichoM Margarida Cardoso
Aug 12, 2010·Journal of the American Chemical Society·Jin WangJoseph M Desimone
Sep 17, 2010·Pharmaceutical Research·Murali Mohan YallapuVinod Labhasetwar
Nov 26, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Tingjun LeiAnthony J McGoron
Jan 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marina TalelliWim E Hennink
Apr 16, 2011·Nano Letters·Constantin UngureanuTon G van Leeuwen
Jun 28, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elham SadeqzadehS Moein Moghimi
Aug 30, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael A SandovalZhengrong Cui
Nov 15, 2011·Archives of Pharmacal Research·Pantiwa IangcharoenPornngarm Limtrakul
Jul 10, 2014·Journal of Cancer Research and Clinical Oncology·Remon BazakTamer Refaat
Aug 25, 2015·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ja Hye MyungSeungpyo Hong
Mar 18, 2016·International Journal of Molecular Sciences·John C LeachSha Jin
Feb 28, 2017·Physical Chemistry Chemical Physics : PCCP·Soumalya MukherjeeAnju Chadha
Mar 3, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Libin ZhangJiyuan Yang
Apr 30, 2017·Chemical Science·Daniel A RichardsVijay Chudasama

❮ Previous
Next ❯

Citations

Jun 12, 2021·Bioconjugate Chemistry·Dvir PoplingerLeonid Patsenker
May 31, 2021·Drug Delivery and Translational Research·Yuan Rui, Jordan J Green

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved